Browsing by Person Plöderl, Martin

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  

Showing results 15 to 34 of 34 < previous 
Issue DateTitleInvolved Person(s)
2021Maintenance therapy with antidepressants : prophylactic effects or withdrawal reactions?Plöderl, Martin; Hengartner, Michael P.
17-Nov-2020Moon and suicide : a true effect or a false-positive finding?Plöderl, Martin; Hengartner, Michael Pascal
9-Feb-2023No clear evidence of reduced brain serotonin release capacity in patients with depressionHengartner, Michael P.; Plöderl, Martin
5-Aug-2023Observational studies of antidepressant use and suicide risk are selectively published in psychiatric journalsPlöderl, Martin; Amendola, Simone; Hengartner, Michael P.
2021Prophylactic effects or withdrawal reactions? : an analysis of time-to-event data from antidepressant relapse prevention trials submitted to the FDAHengartner, Michael Pascal; Plöderl, Martin
2023Publication and citation biases in observational studies about antidepressants and suicidesPlöderl, Martin; Hengartner, Michael P.
Sep-2023Re: "A Multicenter Double-Blind, Placebo-Controlled Trial of Escitalopram in Children and Adolescents with Generalized Anxiety Disorder" by Strawn et al. : concerning harm-benefit ratio in a recent trial about Escitalopram for generalized anxiety disorderPlöderl, Martin; Horowitz, Mark A.; Hengartner, Michael P.
2019Reply to the letter to the editor : “newer-generation antidepressants and suicide risk : thoughts on Hengartner and Plöderl’s re-analysis”Hengartner, Michael Pascal; Plöderl, Martin
Jan-2020Sertraline in primary care : comments on the PANDA trialHengartner, Michael Pascal; Plöderl, Martin; Braillon, Alain; Jakobsen, Janus C.; Gluud, Christian
2018Starting two antidepressants to prevent suicide : a potentially dangerous recommendation?Hengartner, Michael Pascal; Plöderl, Martin
2018Statistically significant antidepressant-placebo differences on subjective symptom-rating scales do not prove that the drugs work : effect Size and method bias matter!Hengartner, Michael P.; Plöderl, Martin
2021Suicidality and other severe psychiatric events with duloxetine : re-analysis of safety data from a placebo-controlled trial for juvenile fibromyalgiaHengartner, Michael Pascal; Plöderl, Martin
2024Suicidality emerging from rapid Venlafaxine discontinuationKostic, Milutin; Plöderl, Martin; Hengartner, Michael; Buzejic, Jelena
14-Feb-2024Suicide rates and prescription of antidepressantsAmendola, Simone; Plöderl, Martin; Hengartner, Michael Pascal
2021Suicide risk with selective serotonin reuptake inhibitors and other new-generation antidepressants in adults: a systematic review and meta-analysis of observational studiesHengartner, Michael Pascal; Amendola, Simone; Kaminski, Jakob A.; Kindler, Simone; Bschor, Tom, et al
2021Suicide risk with selective serotonin reuptake inhibitors and other new-generation serotonergic-noradrenergic antidepressants in adults : a meta-analysis of observational studiesHengartner, Michael P.; Plöderl, Martin; Amendola, Simone; Kindler, Simone; Bschor, Tom, et al
2022Suizidpräventive Effekte von Ketamin und EsketaminPlöderl, Martin; Hengartner, Michael P.; Volkmann, Constantin
16-Jun-2023The serotonin hypothesis of depression : both long discarded and still supported?Moncrieff, Joanna; Cooper, Ruth E.; Stockmann, Tom; Amendola, Simone; Hengartner, Michael P., et al
2019What are the chances for personalised treatment with antidepressants? : detection of patient-by-treatment interaction with a variance ratio meta-analysisPlöderl, Martin; Hengartner, Michael Pascal
Nov-2019Wirken Antidepressiva bei schweren Depressionen besser als bei leichten?Hengartner, Michael Pascal; Plöderl, Martin